Annual report pursuant to Section 13 and 15(d)

Research and Development As Follows (Details)

v2.4.0.6
Research and Development As Follows (Details) (USD $)
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Research expenses were approximately $ 137,000 $ 42,000
Clinical Studies Expenses $ 540,000 $ 336,000